Induction Chemotherapy‐Related Covert Cardiac Remodeling in Pre‐Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Retrospective Observational Study
Induction chemotherapy, administered prior to ASCT in patients with MM, can lead to the emergence or aggravation of cardiac diastolic dysfunction and increase the incidence of arrhythmic events. Therefore, it is crucial to emphasize the importance of balancing the benefits and risks of induction chemotherapy to maximize its efficacy while minimizing CVT.
Authors
- Chang Dai (ORCID: https://orcid.org/0000-0002-5144-4256)
- Jiang Yu (ORCID: https://orcid.org/0000-0001-7378-158X)
- Yidong Lv
- Weidong Lin (ORCID: https://orcid.org/0009-0002-2526-7695)
- Zheng Jian-hong (ORCID: https://orcid.org/0009-0002-2423-324X)
- Yuhan Chen (ORCID: https://orcid.org/0000-0002-2950-2675)
- Fangzhou Liu (ORCID: https://orcid.org/0000-0001-9204-5481)
- Yumei Xue (ORCID: https://orcid.org/0000-0001-7354-0014)
- Xin Chen (ORCID: https://orcid.org/0000-0003-4796-4352)
- Shulin Wu (ORCID: https://orcid.org/0000-0001-9721-3077)
- Xin Du (ORCID: https://orcid.org/0000-0003-2648-9433)
- Hai Deng (ORCID: https://orcid.org/0000-0002-3285-441X)
- Jiaojiao Bai
Institutions
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/cam4.70329
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00